157 related articles for article (PubMed ID: 24594772)
21. Phase I dose escalation study of carboplatin to a fixed dose of irinotecan as first-line treatment of small cell lung cancer.
Schmittel A; Schulze K; Hütter G; Krebs P; Thiel E; Keilholz U
Onkologie; 2004 Jun; 27(3):280-4. PubMed ID: 15249718
[TBL] [Abstract][Full Text] [Related]
22. [Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases].
Sakuma T; Yoshida T; Ohashi H; Nishimura K; Kawano K
Hinyokika Kiyo; 2007 Jul; 53(7):489-92. PubMed ID: 17702184
[TBL] [Abstract][Full Text] [Related]
23. [A case of small cell carcinoma of the ureter].
Masui K; Kamba T; Watanabe J; Soda T; Yoshimura K; Kanematsu A; Nakamura E; Nishiyama H; Ito N; Kamoto T; Ogawa O
Hinyokika Kiyo; 2008 Jun; 54(6):411-3. PubMed ID: 18634436
[TBL] [Abstract][Full Text] [Related]
24. A case of esophageal small cell carcinoma with multiple liver metastases responding to chemotherapy with irinotecan plus cisplatin.
Endo K; Kohnoe S; Toh Y; Haraguchi M; Nishiyama K; Okamura T; Baba H; Maehara Y
J Exp Clin Cancer Res; 2005 Dec; 24(4):647-50. PubMed ID: 16471329
[TBL] [Abstract][Full Text] [Related]
25. [Study of the hormone-refractory prostate cancer clinical practice in an anti-cancer center].
Zufferey L; Roques B; Fléchon A; Droz JP
Bull Cancer; 2001 Dec; 88(12):1213-21. PubMed ID: 11792613
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
Lim SC; Park KO; Kim YC; Na KJ; Song H; Bom HS
Cancer Biother Radiopharm; 2000 Aug; 15(4):381-6. PubMed ID: 11041023
[TBL] [Abstract][Full Text] [Related]
27. [Lymph Node Recurrence of Small Cell Carcinoma of the Extrahepatic Bile Ducts Effectively Treated with Cisplatin plus Irinotecan Chemotherapy - Report of a Case].
Katada T; Sakata J; Ando T; Soma D; Yuza K; Toge K; Hirose Y; Ishikawa H; Miura K; Ohashi T; Takizawa K; Takano K; Kobayashi T; Kameyama H; Wakai T
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2083-2085. PubMed ID: 28133229
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of dose-intense chemotherapy with sequential topoisomerase-targeting regimens with irinotecan/oxaliplatin followed by etoposide/carboplatin in chemotherapy naive patients with extensive small cell lung cancer.
Rossman J; Reddy V; Cantor A; Miley D; Robert F
Lung Cancer; 2011 May; 72(2):219-23. PubMed ID: 20934233
[TBL] [Abstract][Full Text] [Related]
29. Serum neuron-specific enolase as a marker of small-cell carcinoma of the esophagus.
Sasajima K; Watanabe M; Ando T; Hao K; Miyashita M; Yamashita K; Onda M; Takubo K
J Clin Gastroenterol; 1990 Aug; 12(4):384-8. PubMed ID: 2168912
[TBL] [Abstract][Full Text] [Related]
30. A weekly combination of carboplatin and irinotecan for previously untreated extensive disease small-cell lung cancer, results of a minimum follow-up of 3 years: a multi-center Phase II trial JMTO LC02-02.
Okishio K; Mio T; Kawahara M; Yoshioka H; Yanagihara K; Daimon T; Furuse K
Jpn J Clin Oncol; 2012 May; 42(5):387-93. PubMed ID: 22430871
[TBL] [Abstract][Full Text] [Related]
31. [Clinical evaluation of serum NSE (neuron specific enolase) levels in cases of small cell lung cancer].
Moriya H; Hisa S; Satoh T; Suzuki S; Kimura K; Higuchi Y; Hoshi K
Rinsho Hoshasen; 1988 Jan; 33(1):31-4. PubMed ID: 2835529
[No Abstract] [Full Text] [Related]
32. [Small cell carcinoma of the prostate effectively treated for relatively long term: a case report].
Horie K; Kameyama K; Mizutani K; Sugawara T; Seike K; Tsuchiya T; Yasuda M; Yokoi S; Nakano M; Deguchi T; Suzui N; Hirose Y
Hinyokika Kiyo; 2014 Oct; 60(10):517-21. PubMed ID: 25391785
[TBL] [Abstract][Full Text] [Related]
33. Is undetectable prostate-specific antigen always reliable to rule out prostate cancer recurrence after radical prostatectomy?
Schriefer P; Steurer S; Huland H; Graefen M
J Clin Oncol; 2012 Nov; 30(32):e341-4. PubMed ID: 23032622
[No Abstract] [Full Text] [Related]
34. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
35. Irinotecan and carboplatin in metastatic or recurrent non-small-cell lung cancer.
Govindan R; Read W; Faust J; Mc Leod H
Oncology (Williston Park); 2003 Jul; 17(7 Suppl 7):27-9. PubMed ID: 12886871
[TBL] [Abstract][Full Text] [Related]
36. Does small-cell phenotype predict the natural history of prostate cancer? A case study in disease behavior.
Slovin SF
Nat Clin Pract Oncol; 2007 Sep; 4(9):551-4. PubMed ID: 17728713
[TBL] [Abstract][Full Text] [Related]
37. [METASTATIC SMALL CELL CARCINOMA OF THE URINARY BLADDER TREATED WITH SYSTEMIC CHEMOTHERAPY INCLUDING AN AMRUBICIN; A CASE REPORT].
Naito A; Matsumoto A; Odani K; Sato Y; Azuma T; Ishizawa M; Nagase Y; Oshi M; Homma Y
Nihon Hinyokika Gakkai Zasshi; 2016; 107(1):34-38. PubMed ID: 28132989
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of weekly carboplatin and irinotecan as first-line chemotherapy for patients with advanced non-small cell lung cancer.
Kim HS; Kim JH; Kim B; Choi HC; Kwon JH; Choi DR
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1591-7. PubMed ID: 23568282
[TBL] [Abstract][Full Text] [Related]
39. [A case of gastric small cell carcinoma with liver and lymph node metastases responding to CPT-11 plus CDDP chemotherapy].
Segami K; Aoyama T; Hayashi S; Kanazawa A; Hayashi T; Sugano N; Yamamoto N; Sato T; Yukawa H; Oshima T; Yoshikawa T; Rino Y; Kunisaki C; Masuda M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2273-5. PubMed ID: 25731493
[TBL] [Abstract][Full Text] [Related]
40. A case of small-cell prostate cancer with a metastasis to the scalp.
Kraft Rovere R; Silva de Lima A; Casemiro KP
Jpn J Clin Oncol; 2013 Nov; 43(11):1156. PubMed ID: 24186938
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
